COVID-19 Resources

HAP is actively monitoring developments and continues to engage with Pennsylvania Department of Health and the Centers for Disease Control and Prevention to provide members with the most current information and resources.

About COVID-19

The Pennsylvania Department of Health provides information about the coronavirus disease 2019 (COVID-19) and state health officials’ efforts to monitor the spread of the virus.

Also on the Department of Health's COVID-19 page:

  • County and zip code maps of cases
  • County data in table form
  • The latest stay-at-home orders by county
  • Testing and contact tracing plans for the commonwealth

This information is updated regularly.

In addition, the Centers for Disease Control and Prevention provides extensive information about COVID-19 at its website, including:

COVID-19's Impact on Hospitals

The COVID-19 pandemic is threatening the sustainability of Pennsylvania hospitals and the communities they serve. View HAP's new infographic in our Resource Center.

HAP Infographic about Hospital Losses from the COVID-19 Pandemic

Online Resources

COVID-19 Treatments

Casirivimab and Imdevimab—Administration together for mild to moderate coronavirus disease in adults and pediatric patients 12 years of age and older and weighing at least 40 kg with positive viral testing results, and who are at high risk for progressing to severe COVID-19.

Baricitinib (Olumiant) in combination with remdesivir (Veklury)—Emergency use for suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO)

Bamlanivimab—Treatment of mild to moderate COVID-19 in adult and pediatric patients with positive SARS-CoV-2 viral testing results and age 12 years and older and weighing at least 40 kilograms

COVID-19 convalescent plasma—Treatment of hospitalized patients with COVID-19

Regiocit replacement solution—Replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT)

Fresenius Kabi Propoven 2%—Maintaining sedation via continuous infusion in patients older than 16 years with suspected or confirmed COVID-10 who require mechanical ventilation in an ICU

Remdesivir for certain hospitalized COVID-19 Patients—Emergency use for treatment of suspected or laboratory confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg

Vaccine Information

Pennsylvania Department of Health Vaccine Toolkit, Created December 1, 2020

COVID-19 Vaccines, U.S. Food and Drug Administration, January 4, 2021

Vaccinating Pregnant and Lactating Patients Against COVID-19, American College of Obstetricians and Gynecologists, December 2020


Moderna COVID-19 Vaccine Frequently Asked Questions, January 5, 2021

Fact Sheet for Health Care Providers, Revised December 2020

Fact Sheet for Recipients and Caregivers, Revised December 2020

FDA Emergency Use Authorization Letter, December 18, 2020

Pfizer-Biontech COVID-19 Vaccine

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine—United States, December 2020

Fact Sheet for Health Care Providers, Revised December 2020

Fact Sheet for Recipients and Caregivers, Revised December 2020

Supplies & PPE

HAP Resources

Federal Resources

Regulatory Policy

The Centers for Medicare & Medicaid Services:


January 21, 2021

Biden Administration Announces National Strategy to Combat COVID-19 Pandemic

During his first full day in office, President Joe Biden signed ten executive orders to address the COVID-19 pandemic, announcing a national strategy to speed the distribution of the COVID-19 vaccine, mandate mask-wearing on public transportation, and increase the production of necessary supplies and personal protective equipment.

January 19, 2021

HAP Statement on Expansion of COVID-19 Vaccine Plan’s Phase 1A

The Pennsylvania Department of Health today announced an expansion of the criteria for phase 1A of the state’s vaccination distribution plan. This aligns Pennsylvania’s vaccine distribution playbook with federal guidance by expanding those eligible to be vaccinated during the current phase to now total 3.5 million people. HAP president and CEO Andy Carter released a statement in response to the announcement.